Simon Dumesnil

CIK: 0001875691

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KTTA

Pasithea Therapeutics Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

KTTA
Pasithea Therapeutics Corp.
May 1, 2026
Award(A)
Stock Option (right to buy)
Direct
152.8K shares-
KTTA
Pasithea Therapeutics Corp.
Nov 28, 2025
Purchase(P)
Direct
33.3K shares at avg. $0.75$25K
KTTA
Pasithea Therapeutics Corp.
Oct 24, 2025
Award(A)
Stock Option (right to buy)
Direct
42.9K shares-

		Type	Shares	Price		Ownership
May 1, 2026	KTTA Pasithea Therapeutics Corp.	Award(A) Stock Option (right to buy)	152,783	-	-	Direct
Nov 28, 2025	KTTA Pasithea Therapeutics Corp.	Purchase(P)	33,333	$0.75	$25,000	Direct
Oct 24, 2025	KTTA Pasithea Therapeutics Corp.	Award(A) Stock Option (right to buy)	42,913	-	-	Direct

1-3 of 3 transactions

About Dumesnil Simon

Dumesnil Simon (SEC CIK 0001875691) files insider reports with the SEC as Director of Pasithea Therapeutics Corp. (KTTA).

Signal8 holds 3 ownership filings by Dumesnil Simon, all Form 4s, filed between Oct 27, 2025 and May 5, 2026. Those filings report 3 transactions, from Oct 24, 2025 to May 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Dumesnil Simon's filings is in MIAMI BEACH, FL.

Recent filings by Dumesnil Simon

May 1, 2026: Grant or award of KTTA derivative securities (Form 4, code A).
Nov 28, 2025: Open-market purchase of KTTA shares (Form 4, code P).
Oct 24, 2025: Grant or award of KTTA derivative securities (Form 4, code A).

Other insiders filing for Pasithea Therapeutics Corp. (KTTA)

Coastlands Capital LP, 10% Owner
Marques Tiago, Chief Executive Officer
STEINMAN LAWRENCE, Director
Schneiderman Daniel H, Chief Financial Officer
Krishnan Kartik, Chief Medical Officer
Leahy Emer, Director

How to read Form 4 transaction codes